
Borja Sangrador
expertMale0.0Global Dominance: 0.00%
Borja Sangrador is a partner at EY and leads the health sector practice. He offers insights into the pharmaceutical industry in Spain, emphasizing its historical development and potential for growth due to a favorable regulatory environment and competitive labor costs. His expertise highlights the importance of investment and innovation in ensuring Spain's strategic autonomy in healthcare.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Borja Sangrador is a partner responsible for the health sector at EY who discusses the historical development of the pharmaceutical industry in Spain.
Pastillas que valen millones: la hora de las farmacéuticas españolas | NegociosEl País·
Spain· 2025-07-20







